期刊文献+

A型肉毒毒素联合红外偏振光治疗带状疱疹后遗神经痛的临床观察 被引量:5

原文传递
导出
摘要 目的观察A型肉毒毒素联合红外偏振光治疗带状疱疹后遗神经痛的临床疗效。方法选取87例带状疱疹后神经痛患者,采用随机数字表法分为3组。红外偏振光治疗组(A组)运用红外偏振光治疗仪照射治疗带状疱疹后神经痛,肉毒素治疗组(B组)应用A型肉毒毒素进行疼痛点皮下注射治疗疱疹后神经痛,联合治疗组(C组)同时应用红外偏振光治疗仪照射患部和肉毒素疼痛点皮下注射治疗带状疱疹后神经痛,调查每例带状疱疹后神经痛患者治疗前3个月、治疗后1个月、治疗后3个月、治疗后6个月带状疱疹后神经痛发作情况,并行简式McGill疼痛问卷表及生活质量评价量表评分,比较带状疱疹后神经痛发作严重程度及其带状疱疹后神经痛恢复状况,观察不良反应。结果A组、B组与C组治疗后1个月、治疗后3个月、治疗后6个月简式McGill疼痛问卷表评分显著低于治疗前评分(P〈0.01),生活质量评价量表评分显著高于治疗前评分(P〈0.01),差异均有统计学意义。C组在治疗后1个月、治疗后3个月、治疗后6个月,SF-MPQ及SF-36评分分别与A组、B组治疗后1个月、治疗后3个月、治疗后6个月相应评分比较差异有统计意义(P〈0.01)。结论A型肉毒毒素疼痛点皮下注射联合红外偏振光治疗带状疱疹后神经痛发作临床疗效显著,不良反应轻微。
出处 《中国医师杂志》 CAS 2012年第1期90-92,共3页 Journal of Chinese Physician
  • 相关文献

参考文献7

  • 1龚寅,汪正平.带状疱疹后遗神经痛的治疗进展[J].上海医学,2010,33(10):970-973. 被引量:34
  • 2Xiao L,Mackey S,Hui H,et al.Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.Pain Med,2010,11(12):1827-1833.
  • 3Sotiriou E,Apalla Z,Panagiotidou D,et al.Severe post-herpetic neuralgia successfully treated with botulinum toxin A:three case reports.Acta Derm Venereol,2009,89(2):214-215.
  • 4Dodick DW.Botulinum neurotoxin for the treatment of migraine and other primary healache disorders:from bench to bedside.Headache,2003,43 Suppl 1:S25-S33.
  • 5Tugnoli V,Capone JG,Eleopra R,et al.Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.Pain,2007,130(1-2):76-83.
  • 6Cui M,Aoki KR.Botulinum toxin type A (BTX-A) reduces inflammatory pain in the rat formalin model.Cephalalgia,2000,20(4):414.
  • 7王立新 姚路红.红外偏振光治疗带状疱疹疗效观察[J].中国激光医学杂志,2010,:369-369.

二级参考文献23

  • 1姜淑钧,郑宝森,史可梅.阿霉素胸椎旁介入技术治疗带状疱疹后遗神经痛1例[J].中国临床康复,2004,8(20):4045-4045. 被引量:3
  • 2潘虎,曹连生.高压氧联合药物治疗带状疱疹后遗神经痛疗效观察[J].中华物理医学与康复杂志,2006,28(9):626-627. 被引量:9
  • 3Johnson R W,Dworkin R H.Treatment of herpes zoster and postherpetic neuralgia.BMJ,2003,326:748-750.
  • 4Sabatowski R,Gálvez R,Cherry D A,et al.Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia:results of a randomised,placebo-controlled clinical trial.Pain,2004,109:26-35.
  • 5Clark A K,Yip P K,Grist J,et al.Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain.Proc Natl Acad Sci USA,2007,104:10655-10660.
  • 6Watkins L R,Milligan E D,Maier S F.Glial activation:a driving force for pathological pain.Trends Neurosci,2001,24:450-455.
  • 7Baptiste D C,Hartwick A T,Jollimore C A,et al.An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death.Mol Pharmacol,2004,66:1113-1122.
  • 8Baptiste D C,Powell K J,Jollimore C A,et al.Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy.Neuroscience,2005,134:575-582.
  • 9Myers R R,Campana W M,Shubayev V I.The role of neuroinflammation in neuropathic pain:mechanisms and therapeutic targets.Drug Discov Today,2006,11:8-20.
  • 10Hanani M.Satellite glial cells in sensory ganglia:from form to function.Brain Res Brain Res Rev,2005,48:457-476.

共引文献33

同被引文献28

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部